Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / American depositary shares, each representing one equity share
-
Shares outstanding
-
834,731,296
-
Total 13F shares
-
20,415,214
-
Share change
-
+1,548,523
-
Total reported value
-
$769,607,321
-
Put/Call ratio
-
0%
-
Price per share
-
$37.70
-
Number of holders
-
142
-
Value change
-
+$59,512,518
-
Number of buys
-
80
-
Number of sells
-
42
Institutional Holders of DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) as of Q4 2018
As of 31 Dec 2018,
DR REDDYS LABORATORIES LTD - American depositary shares, each representing one equity share (RDY) was held by
142 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
20,415,214 shares.
The largest 10 holders included
ROYAL BANK OF CANADA, BlackRock Inc., Commonwealth Bank of Australia, Vanguard Group Inc, RENAISSANCE TECHNOLOGIES LLC, DIMENSIONAL FUND ADVISORS LP, STATE STREET CORP, Mondrian Investment Partners LTD, AQR CAPITAL MANAGEMENT LLC, and Grantham, Mayo, Van Otterloo & Co. LLC.
This page lists
142
institutional shareholders reporting positions in this security
for the Q4 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.